Article History
Accepted: 17 July 2020
First Online: 24 July 2020
Compliance with Ethical Standards
:
: KBS is a consultant for Akcea Therapeutics and Alnylam Pharmaceuticals. KBS serves on the ATTRIBUTE Trial Steering Committee for Eidos Therapeutics.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Informed consent was not required for this review.